GILGAMESH PHARMACEUTICALS
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.
GILGAMESH PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.gilgameshpharmaceutical.com
Total Employee:
11+
Status:
Active
Total Funding:
29.56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag
Similar Organizations
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
What If Ventures
What If Ventures investment in Series A - Gilgamesh Pharmaceuticals
Gaingels
Gaingels investment in Series A - Gilgamesh Pharmaceuticals
Palo Alto Investors
Palo Alto Investors investment in Series A - Gilgamesh Pharmaceuticals
Route 66 Ventures
Route 66 Ventures investment in Series A - Gilgamesh Pharmaceuticals
JLS Fund
JLS Fund investment in Series A - Gilgamesh Pharmaceuticals
Prime Movers Lab
Prime Movers Lab investment in Series A - Gilgamesh Pharmaceuticals
Alumni Ventures
Alumni Ventures investment in Series A - Gilgamesh Pharmaceuticals
Gron Ventures
Gron Ventures investment in Series A - Gilgamesh Pharmaceuticals
Noetic Fund
Noetic Fund investment in Series A - Gilgamesh Pharmaceuticals
Aera VC
Aera VC investment in Seed Round - Gilgamesh Pharmaceuticals
Official Site Inspections
http://www.gilgameshpharmaceutical.com Semrush global rank: 4.35 M Semrush visits lastest month: 2.61 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Gilgamesh Pharmaceuticals"
About - Gilgamesh Pharmaceutical
Gilgamesh's discovery platform provides a state-of-the-art neurocircuitry-focused translational approach to novel drug candidate optimization and selection. The platform aims to identify …See details»
Gilgamesh Pharmaceuticals - Crunchbase Company …
Contact Email [email protected] Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such …See details»
Gilgamesh Pharmaceuticals - Y Combinator
Dec 15, 2022 Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of …See details»
Team - Gilgamesh Pharmaceutical
Leadership Team. We’re a team of world-class scientists, medicinal chemists, inventors and leaders from top academic and biopharmaceutical institutions, tackling the hardest mental …See details»
Gilgamesh Pharmaceuticals - Overview, News & Similar
Dec 14, 2022 Gilgamesh Pharmaceuticals contact info: Phone number: (347) 967-6831 Website: www.gilgameshpharmaceutical.com What does Gilgamesh Pharmaceuticals do? Gilgamesh is …See details»
Gilgamesh Pharmaceuticals - LinkedIn
Gilgamesh Pharmaceuticals | 6,003 followers on LinkedIn. Gilgamesh is a clinical-stage biotech whose vision is to reshape how mental illnesses are treated by shifting away from symptom management ...See details»
Gilgamesh Pharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Gilgamesh Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Gilgamesh Pharmaceuticals Closes On $27 Million …
May 6, 2021 For more information, visit: www.gilgameshpharmaceutical.com. About Prime Movers Lab. Prime Movers Lab invests in breakthrough scientific startups founded by Prime Movers, the inventors who ...See details»
Gilgamesh Builds Team of Pharmaceutical Industry ... - Markets …
NEW YORK, Nov. 11, 2021 /PRNewswire/ -- Gilgamesh Pharmaceuticals, a mental health focused biotechnology company developing novel psychedelic-rela...See details»
Gilgamesh Pharmaceuticals Awarded $14 Million National Institute …
Mar 14, 2024 Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company committed to developing best-in-class, rapid-acting treatments for mental health disorders, today announced …See details»
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration …
May 13, 2024 For further information: Media: Liz Tang, [email protected]; Gavin Mathis, [email protected]; Investors: Liz Shea, [email protected], Laszlo Kiss, …See details»
Mental health biotech startup Gilgamesh Pharmaceuticals closes …
May 7, 2021 Gilgamesh Pharmaceuticals, a mental health science focused biotechnology company utilizing psychedelic-related medicines for the treatment of neuropsychiatric …See details»
Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance …
Dec 15, 2022 For more information, visit: www.gilgameshpharmaceutical.com. About Prime Movers Lab Prime Movers Lab invests in breakthrough scientific startups founded by Prime …See details»
Gilgamesh Builds Team of Pharmaceutical Industry Leaders and …
NEW YORK, Nov. 11, 2021 /PRNewswire/ -- Gilgamesh Pharmaceuticals, a mental health focused biotechnology company developing novel psychedelic-related medicines for the …See details»
Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round
NEW YORK, May 6, 2021 /PRNewswire/ — Gilgamesh Pharmaceuticals, a mental health science focused biotechnology company utilizing psychedelic-related medicines for the treatment of …See details»
Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD …
Nov 30, 2023 Gilgamesh Pharmaceuticals, a clinical-stage neuroscience biotech developing best-in-class medicines to redefine mental healthcare, announces the successful completion …See details»
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration …
May 13, 2024 - Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of …See details»
Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD …
Nov 30, 2023 Single IV doses of GM-2505, a novel 5HT2A receptor agonist, demonstrated psychedelic effects lasting 60-90 minutes and were well-tolerated with no serious or severe …See details»